Suppr超能文献

通过靶向二代测序鉴定中国常染色体显性遗传性多囊肾病患者PKD1基因的新突变

Identification of novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease by targeted next-generation sequencing.

作者信息

Yang Tao, Meng Yan, Wei Xiaoming, Shen Jiandong, Zhang Mingrong, Qi Chen, Wang Chundan, Liu Jiayin, Ma Minrui, Huang Shangzhi

机构信息

Department of Medical Genetics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, WHO Collaborating Centre for Community Control of Hereditary Diseases, Beijing, China.

Department of Medical Genetics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, WHO Collaborating Centre for Community Control of Hereditary Diseases, Beijing, China.

出版信息

Clin Chim Acta. 2014 Jun 10;433:12-9. doi: 10.1016/j.cca.2014.02.011. Epub 2014 Feb 26.

Abstract

BACKGROUND

Mutations of PKD1 and PKD2 accounted for the most cases of autosomal dominant polycystic kidney disease (ADPKD). The presence of the large transcript, numerous exons and complex reiterated regions within the gene has significantly complicated the analysis of PKD1 with routine PCR-based approaches.

METHODS

We developed a strategy to analyze both the PKD1/PKD2 genes simultaneously using targeted next-generation sequencing (NGS). All coding exons plus the flanking sequences of PKD1 and PKD2 genes from probands were captured, individually barcoded and followed by HiSeq2000 sequencing. The candidate variants were validated by using classic Sanger sequencing. PKD1-specific primers were designed to amplify the replicated areas of PKD1 gene.

RESULTS

Five novel variations and one known mutation in PKD1 gene were detected in five familial and one sporadic Chinese ADPKD patients. Through pedigree and bioinformatic analysis, five of them were identified as pathogenic mutations (p.G1319R, p.Y3781*, p.W4122*, p.Val700Glyfs14, and p.Leu3656Trpfs28) and one was as polymorphism (p.T2420I).

CONCLUSIONS

Our result showed that targeted capture and NGS technology were effective for the gene testing of ADPKD disorder. Mutation study of PKD1 and PKD2 genes in Chinese patients may contribute to better understanding of the genetic diversity between different ethnic groups and enrich the mutation database in Asian population.

摘要

背景

PKD1和PKD2突变是常染色体显性多囊肾病(ADPKD)最常见的病因。该基因存在大量转录本、众多外显子以及复杂的重复区域,这使得运用常规基于聚合酶链反应(PCR)的方法对PKD1进行分析变得极为复杂。

方法

我们研发了一种策略,通过靶向新一代测序(NGS)同时分析PKD1/PKD2基因。从先证者中捕获PKD1和PKD2基因的所有编码外显子及其侧翼序列,分别进行条形码标记,随后进行HiSeq2000测序。利用经典的桑格测序法对候选变异进行验证。设计PKD1特异性引物以扩增PKD1基因的重复区域。

结果

在5例家族性和1例散发的中国ADPKD患者中检测到PKD1基因的5个新变异和1个已知突变。通过系谱和生物信息学分析,其中5个被鉴定为致病突变(p.G1319R、p.Y3781*、p.W4122*、p.Val700Glyfs14和p.Leu3656Trpfs28),1个为多态性(p.T2420I)。

结论

我们的结果表明,靶向捕获和NGS技术对ADPKD疾病的基因检测是有效的。对中国患者PKD1和PKD2基因的突变研究可能有助于更好地理解不同种族之间的遗传多样性,并丰富亚洲人群的突变数据库。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验